Abortion

This brief examines what the November election and prior efforts to enshrine abortion rights at the ballot box mean for those states and what’s next, including the future of abortion restrictions in states where voters enshrined abortion rights where abortion was banned or restricted, as well as those that do not have abortion bans.

KFF’s analysis of KFF/AP VoteCast supplemental questions shows how abortion, abortion-related ballot measures, and other health care issues influenced the 2024 election.

The upcoming election is looking more and more like a fork in the road for U.S. health policy. KFF Health News’ chief Washington correspondent and podcast host Julie Rovner and a panel of top policy experts and journalists discussed this pivotal moment in health care politics and took questions from the audience. 

The Supreme Court’s ruling in Medina v. Planned Parenthood of the South Atlantic means that Medicaid enrollees in South Carolina, and in other states that exclude Planned Parenthood going forward, will not be able to use their Medicaid coverage to obtain any preventive services, such as contraceptive care, STI treatment and cancer screenings, at Planned Parenthood clinics.

On April 24, the Supreme Court will hear Idaho v. United States—the second case this term involving access to abortion. In a new brief, KFF examines what’s at stake, focusing on whether the Emergency Medical Treatment and Active Labor Act (EMTALA)—a federal law requiring nearly all hospitals to ensure emergency…

This brief reviews the different sources of abortion data in the United States, the factors that have affected abortion rates across the U.S, before and after Roe v. Wade, and what we may see as the Trump administration, Republican majorities in the House and Senate, and a conservative federal judiciary shape policy in the coming years.

To improve the affordability of abortion services, many states have passed laws that require state-regulated plans to cover the full cost of abortion services for their enrollees. This data note documents the costs associated with abortion care in private plans. Also, KFF analyzes how out of pocket spending has been affected by state laws that require full coverage of abortion services.

This data note analyzes employer-sponsored insurance and Medicaid claims data to see how mifepristone and misoprostol—two drugs used in the medication abortion regimen—are prescribed for reasons other than abortion including management of miscarriages, abnormal bleeding or hemorrhage, as well as IUD insertions and other conditions.

In a new brief, KFF explores how abortion bans and restrictions in the aftermath of the Supreme Court’s 2022 Dobbs decision can further complicate pregnancy loss.  Pregnancy loss, which includes miscarriage and stillbirth, is common, and for many people, it is a physically, mentally, and emotionally taxing experience. The medical…

This issue brief presents data from the most recent tracking poll asking if people have ever visited a Planned Parenthood clinic for health care services and looks at the funding cuts Planned Parenthood is currently facing including Medicaid, Title X, and Teen Pregnancy Prevention funds.